表紙
市場調查報告書

B型血友病:全球臨床實驗趨勢

Hemophilia B (Factor IX Deficiency) Global Clinical Trials Review, H2, 2019

出版商 GlobalData 商品編碼 212846
出版日期 內容資訊 英文 173 Pages
訂單完成後即時交付
價格
Back to Top
B型血友病:全球臨床實驗趨勢 Hemophilia B (Factor IX Deficiency) Global Clinical Trials Review, H2, 2019
出版日期: 2019年12月06日內容資訊: 英文 173 Pages
簡介

本報告提供B型血友病相關之臨床研究最新趨勢分析,提供您疾病·治療方法概要,及G7及E7各國的臨床實驗狀況,各地區、各階段的進行狀況,有潛力的贊助商,各企業及研究機關的研究進行狀況,並彙整有潛力的藥劑比較等資訊。

本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 前五名國家的臨床實驗數量; 亞太地區
    • 前五名國家的臨床實驗數量; 歐洲
    • 主要國家的臨床實驗數量; 北美
    • 前五名國家的臨床實驗數量; 中東/非洲地區
    • 前五名國家的臨床實驗數量; 中南美

G7各國的臨床實驗數量:B型血友病臨床實驗數量上血液疾病臨床實驗數量比率

各期臨床實驗數量: G7各國

G7各國的臨床實驗數量:各期

E7各國的臨床實驗數量:B型血友病臨床實驗數量上血液疾病臨床實驗數量比率

各期臨床實驗數量: E7各國

E7各國的臨床實驗數量:各期

各期臨床實驗數量

  • 各期的進展中臨床實驗數量

各進展狀況臨床實驗數量

評估項目別臨床實驗數量

一定期間所採用的受驗人數

贊助商類別的臨床實驗數量

有潛力的贊助商

臨床實驗主要參加企業 - B型血友病治療藥

有潛力的藥劑

最新臨床實驗新聞:B型血友病

臨床實驗簡介的基本資料

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC5172CTIDB

GlobalData's clinical trial report, "Hemophilia B (Factor IX Deficiency) Global Clinical Trials Review, H2, 2019" provides an overview of Hemophilia B (Factor IX Deficiency) clinical trials scenario. This report provides top line data relating to the clinical trials on Hemophilia B (Factor IX Deficiency) . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

  • List of Tables 4
  • List of Figures 5
  • Report Guidance 6
  • GlobalData Clinical Trials Report Coverage 7
  • Clinical Trials by Region 8
  • Clinical Trials and Average Enrollment by Country 9
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
  • Top Five Countries Contributing to Clinical Trials in Europe 13
  • Top Countries Contributing to Clinical Trials in North America 14
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15
  • Top Five Countries Contributing to Clinical Trials in Central and South America 16
  • Clinical Trials by G7 Countries: Proportion of Hemophilia B (Factor IX Deficiency) to Hematological Disorders Clinical Trials 17
  • Clinical Trials by Phase in G7 Countries 18
  • Clinical Trials in G7 Countries by Trial Status 19
  • Clinical Trials by E7 Countries: Proportion of Hemophilia B (Factor IX Deficiency) to Hematological Disorders Clinical Trials 20
  • Clinical Trials by Phase in E7 Countries 21
  • Clinical Trials in E7 Countries by Trial Status 22
  • Clinical Trials by Phase 23
  • In Progress Trials by Phase 24
  • Clinical Trials by Trial Status 25
  • Clinical Trials by End Point Status 26
  • Subjects Recruited Over a Period of Time 27
  • Clinical Trials by Sponsor Type 28
  • Prominent Sponsors 29
  • Top Companies Participating in Hemophilia B (Factor IX Deficiency) Therapeutics Clinical Trials 31
  • Prominent Drugs 32
  • Latest Clinical Trials News on Hemophilia B (Factor IX Deficiency) 33
  • Nov 06, 2019: uniQure announces clinical data presentations at the 61st American Society of Hematology (ASH) Annual Meeting 33
  • Oct 31, 2019: uniQure announces publication of positive interim data from phase IIb clinical trial of Etranacogene Dezaparvovec 33
  • Oct 03, 2019: Catalyst Biosciences provides DalcA Phase 2b Trial Update 34
  • Sep 27, 2019: uniQure to present clinical trial detials of AMT-061 at National Hemophilia Foundation 71st Bleeding Disorders Conference 34
  • Clinical Trial Profile Snapshots 35

Appendix 172

  • Abbreviations 172
  • Definitions 172
  • Research Methodology 173
  • Secondary Research 173
  • About GlobalData 174
  • Contact Us 174
  • Source 175

List of Tables

  • Hemophilia B (Factor IX Deficiency) Therapeutics, Global, Clinical Trials by Region, 2019* 8
  • Hemophilia B (Factor IX Deficiency) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 10
  • Hemophilia B (Factor IX Deficiency) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11
  • Hemophilia B (Factor IX Deficiency) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019* 12
  • Hemophilia B (Factor IX Deficiency) Therapeutics Clinical Trials, Europe, Top Five Countries, 2019* 13
  • Hemophilia B (Factor IX Deficiency) Therapeutics Clinical Trials, North America, Top Countries, 2019* 14
  • Hemophilia B (Factor IX Deficiency) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2019* 15
  • Hemophilia B (Factor IX Deficiency) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2019* 16
  • Proportion of Hemophilia B (Factor IX Deficiency) to Hematological Disorders Clinical Trials, G7 Countries (%), 2019* 17
  • Hemophilia B (Factor IX Deficiency) Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 18
  • Hemophilia B (Factor IX Deficiency) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 19
  • Proportion of Hemophilia B (Factor IX Deficiency) to Hematological Disorders Clinical Trials, E7 Countries (%), 2019* 20
  • Hemophilia B (Factor IX Deficiency) Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 21
  • Hemophilia B (Factor IX Deficiency) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 22
  • Hemophilia B (Factor IX Deficiency) Therapeutics, Global, Clinical Trials by Phase, 2019* 23
  • Hemophilia B (Factor IX Deficiency) Therapeutics, Global, Clinical Trials In Progress by Phase 2019* 24
  • Hemophilia B (Factor IX Deficiency) Therapeutics, Global, Clinical Trials by Trial Status, 2019* 25
  • Hemophilia B (Factor IX Deficiency) Therapeutics Clinical Trials, Global, by End Point Status, 2019* 26
  • Hemophilia B (Factor IX Deficiency) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 27
  • Hemophilia B (Factor IX Deficiency) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019* 28
  • Hemophilia B (Factor IX Deficiency) Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 30
  • Hemophilia B (Factor IX Deficiency) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 31
  • Hemophilia B (Factor IX Deficiency) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 32

List of Figures

  • Hemophilia B (Factor IX Deficiency) Therapeutics, Global, Clinical Trials by Region (%), 2019* 8
  • Hemophilia B (Factor IX Deficiency) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9
  • Hemophilia B (Factor IX Deficiency) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11
  • Hemophilia B (Factor IX Deficiency) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019* 12
  • Hemophilia B (Factor IX Deficiency) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019* 13
  • Hemophilia B (Factor IX Deficiency) Therapeutics Clinical Trials, North America, Top Countries (%), 2019* 14
  • Hemophilia B (Factor IX Deficiency) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2019* 15
  • Hemophilia B (Factor IX Deficiency) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2019* 16
  • Proportion of Hemophilia B (Factor IX Deficiency) to Hematological Disorders Clinical Trials, G7 Countries (%), 2019* 17
  • Hemophilia B (Factor IX Deficiency) Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 18
  • Hemophilia B (Factor IX Deficiency) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 19
  • Proportion of Hemophilia B (Factor IX Deficiency) to Hematological Disorders Clinical Trials, E7 Countries (%), 2019* 20
  • Hemophilia B (Factor IX Deficiency) Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 21
  • Hemophilia B (Factor IX Deficiency) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 22
  • Hemophilia B (Factor IX Deficiency) Therapeutics, Global, Clinical Trials by Phase (%), 2019* 23
  • Hemophilia B (Factor IX Deficiency) Therapeutics, Global, Clinical Trials In Progress by Phase, 2019* 24
  • Hemophilia B (Factor IX Deficiency) Therapeutics, Global, Clinical Trials by Trial Status, 2019* 25
  • Hemophilia B (Factor IX Deficiency) Therapeutics Clinical Trials, Global, by End Point Status, 2019* 26
  • Hemophilia B (Factor IX Deficiency) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 27
  • Hemophilia B (Factor IX Deficiency) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019* 28
  • Hemophilia B (Factor IX Deficiency) Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 29
  • Hemophilia B (Factor IX Deficiency) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 31
  • Hemophilia B (Factor IX Deficiency) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 32
  • GlobalData Methodology 173
Back to Top